Our results of elevated CCL17 and CCL22 levels in peripheral blood from morbidly obese patients suggest that these chemokines may play a role in leukocyte trafficking and endothelial dysfunction in obesity, in addition to their role as chemoattractants in the adipose tissue milieu (21). This evidence concerns the gene CCL17 and endothelial dysfunction.